Literature DB >> 27687503

Candida vulvovaginitis: A store with a buttery and a show window.

Gilbert G G Donders1,2, Jack D Sobel3.   

Abstract

Although being an utterly frequent, non-mortal, yet distressing disease, and despite good knowledge of the pathogenesis and the availability of specific and safe treatment, vulvovaginal Candida (VVC) infection remains one of the most enigmatic problems for both physicians and patients. Good treatment requires a proper diagnosis. Too many caregivers (and patients treating themselves) react too simple-minded on the symptoms of VVC and treat VVC where they see it on the vulva. In this opinion paper, we plea for a thorough examination of women with VVC, especially in those women who suffer from recurrent disease since a long time, sometimes decades, which necessitates intensive examination of the vaginal flora, as this is invariably the reservoir for relapses and recurrent vulvitis. Examination of such complicated cases requires experienced clinical judgement, expertise bedside phase contrast microscopy of fresh vaginal fluid, classical cultures on Sabouroud medium and, if still unresolved, repetitive cultures taken by the patient herself at moments of symptoms, and/or nuclear acid amplification techniques to detect Candida genes in the vaginal fluid. Even if only vulvitis is evident, thorough expert examination of vaginal fluid is obligatory to diagnose VVC.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  NAAT; candidosis; recurrent vulvovaginal candidiasis; vaginitis; wet mount microscopy

Mesh:

Substances:

Year:  2016        PMID: 27687503     DOI: 10.1111/myc.12572

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).

Authors:  P Vieira-Baptista; G Donders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-26       Impact factor: 3.267

2.  In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.

Authors:  Maurizio Sanguinetti; Emilia Cantón; Riccardo Torelli; Fabio Tumietto; Ana Espinel-Ingroff; Brunella Posteraro
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 3.  Stryphnodendron Species Known as "Barbatimão": A Comprehensive Report.

Authors:  Tatiana M Souza-Moreira; Geisiany M Queiroz-Fernandes; Rosemeire C L R Pietro
Journal:  Molecules       Date:  2018-04-15       Impact factor: 4.411

4.  Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi'an: A Cross-Sectional Study.

Authors:  Xianling Zeng; Yafei Zhang; Taohong Zhang; Yan Xue; Huiqiu Xu; Ruifang An
Journal:  Biomed Res Int       Date:  2018-06-07       Impact factor: 3.411

Review 5.  Interplay Between the Host, the Human Microbiome, and Drug Metabolism.

Authors:  Robert G Nichols; Jeffrey M Peters; Andrew D Patterson
Journal:  Hum Genomics       Date:  2019-06-11       Impact factor: 4.639

Review 6.  Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis.

Authors:  Mohd Sajjad Ahmad Khan; Fatimah Alshehrei; Saleh Bakheet Al-Ghamdi; Majid Abdullah Bamaga; Abdullah Safar Al-Thubiani; Mohammad Zubair Alam
Journal:  Future Sci OA       Date:  2020-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.